K Jagannadha Sastry

Title: K Jagannadha Sastry: Innovator in HIV Research

Introduction

K Jagannadha Sastry is a notable inventor based in Bastrop, TX (US), recognized for his contributions to the field of HIV research. He holds two patents that focus on innovative diagnostic, preventative, and treatment therapies for AIDS. His work is significant in advancing the understanding and management of HIV.

Latest Patents

Sastry's latest patents revolve around HIV-specific T-cell induction. This invention discloses methods for determining whether a subject exhibits an HLA-Cw7-restricted CTL response. Some methods utilize HLA-Cw7 as a genetic marker for long-term non-progression and suitability for treatment therapies. The diagnostic methods include predicting long-term non-progression in HIV-infected subjects. Additionally, the preventative and treatment methods involve determining whether a subject can exhibit an HLA-Cw7-restricted CTL response. They also explore ways to elicit such a response if necessary. Furthermore, some methods involve administering HIV polypeptides or peptides, or polynucleotides encoding them, as treatment therapies to prevent the development of AIDS.

Career Highlights

K Jagannadha Sastry is affiliated with the University of Texas System, where he continues to contribute to research and innovation in the field of HIV. His work has garnered attention for its potential impact on the treatment and management of AIDS.

Collaborations

Some of his notable coworkers include Ralph B Arlinghaus and Pramod N Nehete, who collaborate with him on various research initiatives.

Conclusion

K Jagannadha Sastry's innovative work in HIV research highlights his commitment to improving diagnostic and treatment methods for AIDS. His contributions are vital in the ongoing fight against this global health challenge.